Cargando…

Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy

BACKGROUND: An increased risk of breast cancer following radiotherapy for Hodgkin lymphoma (HL) has now been robustly established. In order to estimate the dose–response relationship more accurately, and to aid clinical decision making, a retrospective estimation of the radiation dose delivered to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russell, Nicola S., Krul, Inge M., van Eggermond, Anna M., Aleman, Berthe M.P., Cooke, Rosie, Kuiper, Susanne, Allen, Steven D., Wallis, Matthew G., Llanas, Damien, Diallo, Ibrahima, de Vathaire, Florent, Smith, Susan A., Hauptmann, Michael, Broeks, Annegien, Swerdlow, Anthony J., Van Leeuwen, Flora E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862668/ https://www.ncbi.nlm.nih.gov/pubmed/29594225 http://dx.doi.org/10.1016/j.ctro.2017.09.004

Ejemplares similares

Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors
por: Roberti, Sander, et al.
Publicado: (2022)

Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin’s lymphoma: influence on long-term adverse effects (SOPHIA)
por: Krul, Inge M, et al.
Publicado: (2018)

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
por: Cutter, David J., et al.
Publicado: (2015)

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors
por: van Eggermond, Anna M, et al.
Publicado: (2017)

Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases
por: Ykema, Berbel L. M., et al.
Publicado: (2020)

Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer
por: Rigter, Lisanne S., et al.
Publicado: (2018)

Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics
por: de Vries, Simone, et al.
Publicado: (2018)

Genome-wide homozygosity signature and risk of Hodgkin lymphoma
por: Sud, Amit, et al.
Publicado: (2015)

P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands
por: Lammers, Eline M.J., et al.
Publicado: (2022)

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
por: de Vries, Simone, et al.
Publicado: (2020)

Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer
por: Rigter, Lisanne S., et al.
Publicado: (2022)

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors
por: de Vries, Simone, et al.
Publicado: (2018)

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
por: Broeks, Annegien, et al.
Publicado: (2007)

Surgical outcomes following breast reconstruction in patients with and without a history of chest radiotherapy for Hodgkin lymphoma: a multicentre, matched cohort study
por: Harmeling, J. Xavier, et al.
Publicado: (2023)

P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
por: Geurts, Yvonne M.G., et al.
Publicado: (2022)

P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs?
por: Nijdam, Annelies, et al.
Publicado: (2022)

Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data
por: Juul, Sidsel Jacobsen, et al.
Publicado: (2022)

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
por: Ykema, Berbel L.M., et al.
Publicado: (2022)

Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma
por: Geurts, Yvonne M., et al.
Publicado: (2023)

Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
por: Jacobse, Judy N., et al.
Publicado: (2019)

Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
por: Ykema, Berbel, et al.
Publicado: (2020)

Heart failure after treatment for breast cancer
por: Boekel, Naomi B., et al.
Publicado: (2019)

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors
por: Rigter, Lisanne S., et al.
Publicado: (2018)

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study
por: Broeks, Annegien, et al.
Publicado: (2007)

Experimental assessment of out‐of‐field dose components in high energy electron beams used in external beam radiotherapy
por: Alabdoaburas, Mohamad M., et al.
Publicado: (2015)

Analytical models for external photon beam radiotherapy out-of-field dose calculation: a scoping review
por: Benzazon, Nathan, et al.
Publicado: (2023)

Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin’s lymphoma survivors
por: Ykema, Berbel L. M., et al.
Publicado: (2021)

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study
por: Busson, Raphaël, et al.
Publicado: (2019)

A genome-wide association study of Hodgkin Lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21, and 10p14 (GATA3)
por: Enciso-Mora, Victor, et al.
Publicado: (2010)

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design
por: Rigter, Lisanne S., et al.
Publicado: (2017)

Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009
por: Duane, Frances K., et al.
Publicado: (2022)

Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
por: Boekel, Naomi B., et al.
Publicado: (2014)

Topographic variability of the normal circle of Willis anatomy on a paediatric population
por: Zrafi, Wael, et al.
Publicado: (2021)

Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion
por: Koppelmans, Vincent, et al.
Publicado: (2020)

T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
por: Neppelenbroek, Suzanne I.M., et al.
Publicado: (2022)

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients
por: Schmidt, Marjanka K, et al.
Publicado: (2009)

Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years
por: Jacobse, Judy N., et al.
Publicado: (2019)

Second primary breast cancer after Hodgkin's disease
por: Horwich, A, et al.
Publicado: (2004)

Cancer-related Fatigue in Relation to Chronotype and Sleep Quality in (Non-)Hodgkin Lymphoma Survivors
por: Starreveld, Daniëlle E. J., et al.
Publicado: (2021)

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer
por: Boekel, Naomi B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jvv15gn33laf7ojvvs0k1bc7eo